Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1987 Apr;23(4):383–389. doi: 10.1111/j.1365-2125.1987.tb03066.x

Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.

W Reid, D J Ewing, J D Harry, H J Smith, J M Neilson, B F Clarke
PMCID: PMC1386086  PMID: 2883987

Abstract

Eight diabetics with autonomic neuropathy were given single oral doses of epanolol (200 mg), atenolol (50 mg), pindolol (5 mg) and placebo in a double-blind randomised order at weekly intervals. Supine resting heart rate, physiological tremor and blood glucose were measured before, 2 and 4 h after dosing, and ambulatory heart rate monitored for 24 h. Supine resting heart rate was significantly lowered by atenolol both at 2 and 4 h, and increased on pindolol at 4 h. Heart rate was unaffected by epanolol compared with placebo. Heart rate during the 'waking' period (14.00-23.00 h) was lower than placebo after epanolol and atenolol but unaffected by pindolol. During the 'sleeping' period (23.00 h-08.00 h) heart rate was significantly increased by pindolol, lowered with atenolol and unaffected on epanolol. Pindolol significantly increased physiological tremor at 4 h. No differences were seen between epanolol, atenolol and placebo. Plasma glucose was significantly increased by pindolol 2 h after dosing. These results suggest that pindolol probably produces its partial agonist activity at both beta 1- and beta 2-adrenoceptors, while the partial agonist activity of epanolol is beta 1-selective. Despite abnormal cardiovascular reflex tests in these diabetics, the heart rate responses obtained in this study after beta-adrenoceptor blockade were surprisingly normal, and suggest that the concept of 'cardiac denervation' in diabetes requires modification.

Full text

PDF
389

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aellig W. H. Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations. Br J Clin Pharmacol. 1982;13(Suppl 2):187S–192S. doi: 10.1111/j.1365-2125.1982.tb01909.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aellig W. H. beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers. Br J Clin Pharmacol. 1976 Apr;3(2):251–257. doi: 10.1111/j.1365-2125.1976.tb00600.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arnold J. M., McDevitt D. G. Enhancement of physiological finger tremor by intravenous isoprenaline infusions in man: evaluation of its role in the assessment of beta-adrenoceptor antagonists. Br J Clin Pharmacol. 1984 Aug;18(2):145–152. doi: 10.1111/j.1365-2125.1984.tb02446.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Arnold J. M., O'Connor P. C., Riddell J. G., Harron D. W., Shanks R. G., McDevitt D. G. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Br J Clin Pharmacol. 1985 May;19(5):619–630. doi: 10.1111/j.1365-2125.1985.tb02689.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barrett A. M., Carter J. Comparative chronotropic activity of beta-adrenoceptive antagonists. Br J Pharmacol. 1970 Nov;40(3):373–381. doi: 10.1111/j.1476-5381.1970.tb10619.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bilski A., Robertson H. H., Wale J. L. A study of the relationship between cardiac beta-adrenoceptor blockade and intrinsic sympathomimetic activity in rats depleted of catecholamines. Clin Exp Pharmacol Physiol. 1979 Jan-Feb;6(1):1–9. doi: 10.1111/j.1440-1681.1979.tb00001.x. [DOI] [PubMed] [Google Scholar]
  7. Brown J. E., McLeod A. A., Shand D. G. Evidence for cardiac beta 2-adrenoceptors in man. Clin Pharmacol Ther. 1983 Apr;33(4):424–428. doi: 10.1038/clpt.1983.57. [DOI] [PubMed] [Google Scholar]
  8. Clark B. J., Menninger K., Bertholet A. Pindolol--the pharmacology of a partial agonist. Br J Clin Pharmacol. 1982;13(Suppl 2):149S–158S. doi: 10.1111/j.1365-2125.1982.tb01904.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ewing D. J., Clarke B. F. Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed) 1982 Oct 2;285(6346):916–918. doi: 10.1136/bmj.285.6346.916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Floras J. S., Jones J. V., Hassan M. O., Sleight P. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol. Br Med J (Clin Res Ed) 1982 Nov 13;285(6352):1387–1392. doi: 10.1136/bmj.285.6352.1387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Harry J. D., Knapp M. F., Linden R. J. The actions of a new beta-adrenoceptor blocking drug, ICI 66082, on the rabbit papillary muscle and on the dog heart. Br J Pharmacol. 1974 Jun;51(2):169–177. doi: 10.1111/j.1476-5381.1974.tb09644.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Harry J. D. The demonstration of atenolol as a beta-adrenoceptor blocking drug in man. Postgrad Med J. 1977;53 (Suppl 3):65–69. [PubMed] [Google Scholar]
  13. Man in 't Veld A. J., Schalekamp M. A. Pindolol acts as beta-adrenoceptor agonist in orthostatic hypotension: therapeutic implications. Br Med J (Clin Res Ed) 1981 Mar 21;282(6268):929–931. doi: 10.1136/bmj.282.6268.929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Man in't Veld A. J., Boomsma F., Schalekamp M. A. Effects of beta-adrenoceptor agonists and antagonists in patients with peripheral autonomic neuropathy. Br J Clin Pharmacol. 1982;13(Suppl 2):367S–374S. doi: 10.1111/j.1365-2125.1982.tb01943.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pringle T. H., O'Connor P. C., McNeill A. J., Finch M. B., Riddell J. G., Shanks R. G. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Br J Clin Pharmacol. 1986 Mar;21(3):249–258. doi: 10.1111/j.1365-2125.1986.tb05187.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Smith H. J., Halliday S. E., Earl D. C., Stribling D. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292. J Pharmacol Exp Ther. 1983 Jul;226(1):211–216. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES